Abstract
Background: The delivery of monetary incentives contingent on verified abstinence is an effective treatment for alcohol use disorder. However, technological barriers to accurate, frequent biochemical verification of alcohol abstinence have limited the dissemination of this technique. Methods: In the present randomized parallel trial, we employed a breathalyzer that allows remote, user-verified collection of a breath alcohol sample, text messaging, and reloadable debit cards for remote delivery of incentives to evaluate a contingency management treatment for alcohol use disorder that can be delivered with no in-person contact. Treatment-seeking participants with alcohol use disorder (n = 40) were recruited from the community and randomized to either a contingent or a noncontingent group (n = 20 each). The contingent group received nearly immediate monetary incentives each day they remotely provided negative breathalyzer samples. The noncontingent group received matched monetary payments each day they successfully provided samples independent of alcohol content. Groups were not masked as awareness of group contingencies was an essential intervention component. Results: The primary outcome of the intent-to-treat analyses (analyzed n = 40) was percent days abstinent as measured by the remote breathalyzer samples. Abstinence rates in the contingent group were 85%, which was significantly higher than the 38% recorded in the noncontingent group, corresponding to an odds ratio of 9.4 (95% CI = 4.0 to 22.2). Breathalyzer collection adherence rates were over 95%, and participant ratings of acceptability were also high. Conclusions: These results support the efficacy, acceptability, and feasibility of this remotely deliverable abstinence reinforcement incentive intervention for the initiation and near-term maintenance of abstinence from alcohol in adults with alcohol use disorder. Due to low provider and participant burden, this procedure has the potential for broad dissemination.
| Original language | English |
|---|---|
| Pages (from-to) | 2423-2431 |
| Number of pages | 9 |
| Journal | Alcoholism: Clinical and Experimental Research |
| Volume | 42 |
| Issue number | 12 |
| DOIs | |
| State | Published - Dec 2018 |
Bibliographical note
Publisher Copyright:2018 The Authors Alcoholism: Clinical & Experimental Research published by Wiley Periodicals, Inc. on behalf of Research Society on Alcoholism
Funding
Research reported in this publication was supported by the National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health under award number R21 AA022727 to MNK. 100% of this research was supported by federal money with no financial or nonfinancial support from nongovernmental sources. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funding source did not have a role in writing this manuscript or in the decision to submit it for publication. All authors had full access to the data in this study, and the corresponding author had final responsibility for the decision to submit these data for publication.
| Funders | Funder number |
|---|---|
| National Institutes of Health (NIH) | |
| National Institute on Alcohol Abuse and Alcoholism | R21AA022727 |
Keywords
- Alcohol Use Disorder
- Breathalyzer
- Contingency Management
- Ecological Momentary Assessment
- Incentives
ASJC Scopus subject areas
- Medicine (miscellaneous)
- Toxicology
- Psychiatry and Mental health
